AISAC: An Artificial Immune System for Associative Classification Applied to Breast Cancer Detection

A Novel Bioinspired Algorithm for Mixed and Incomplete Breast Cancer Data Classification

The pre-diagnosis of cancer has been approached from various perspectives, so it is imperative to continue improving classification algorithms to achieve early diagnosis of the disease and improve patient survival. In the medical field, there are data that, for various reasons, are lost. There are also datasets that mix numerical and categorical values. Very few algorithms classify datasets with such characteristics. Therefore, this study proposes the modification of an existing algorithm for the classification of cancer. The said algorithm showed excellent results compared with classical classification algorithms. The AISAC-MMD (Mixed and Missing Data) is based on the AISAC and was modified to work with datasets with missing and mixed values. It showed significantly better performance than bio-inspired or classical classification algorithms. Statistical analysis established that the AISAC-MMD significantly outperformed the Nearest Neighbor, C4.5, Naïve Bayes, ALVOT, Naïve Associative Classifier, AIRS1, Immunos1, and CLONALG algorithms in conducting breast cancer classification.

Adaptive Diagnosis of Lung Cancer by Deep Learning Classification Using Wilcoxon Gain and Generator

Cancer is a complicated worldwide health issue with an increasing death rate in recent years. With the swift blooming of the high throughput technology and several machine learning methods that have unfolded in recent years, progress in cancer disease diagnosis has been made based on subset features, providing awareness of the efficient and precise disease diagnosis. Hence, progressive machine learning techniques that can, fortunately, differentiate lung cancer patients from healthy persons are of great concern. This paper proposes a novel Wilcoxon Signed-Rank Gain Preprocessing combined with Generative Deep Learning called Wilcoxon Signed Generative Deep Learning (WS-GDL) method for lung cancer disease diagnosis. Firstly, test significance analysis and information gain eliminate redundant and irrelevant attributes and extract many informative and significant attributes. Then, using a generator function, the Generative Deep Learning method is used to learn the deep features. Finally, a minimax game (i.e., minimizing error with maximum accuracy) is proposed to diagnose the disease. Numerical experiments on the Thoracic Surgery Data Set are used to test the WS-GDL method's disease diagnosis performance. The WS-GDL approach may create relevant and significant attributes and adaptively diagnose the disease by selecting optimal learning model parameters. Quantitative experimental results show that the WS-GDL method achieves better diagnosis performance and higher computing efficiency in computational time, computational complexity, and false-positive rate compared to state-of-the-art approaches.

Intelligent immune clonal optimization algorithm for pulmonary nodule classification

Computer-aided diagnosis (CAD) of pulmonary nodules is an effective approach for early detection of lung cancers, and pulmonary nodule classification is one of the key issues in the CAD system. However, CAD has the problems of low accuracy and high false-positive rate (FPR) on pulmonary nodule classification. To solve these problems, a novel method using intelligent immune clonal selection and classification algorithm is proposed and developed in this work. First, according to the mechanism and characteristics of chaotic motion with a logistic mapping, the proposed method utilizes the characteristics of chaotic motion and selects the control factor of the optimal chaotic state, to generate an initial population with randomness and ergodicity. The singleness problem of the initial population of the immune algorithm was solved by the proposed method. Second, considering on the characteristics of Gaussian mutation operator (GMO) with a small scale, and Cauchy mutation operator (CMO) with a big scale, an intelligent mutation strategy is developed, and a novel control factor of the mutation is designed. Therefore, a Gauss-Cauchy hybrid mutation operator is designed. Ultimately, in this study, the intelligent immune clonal optimization algorithm is proposed and developed for pulmonary nodule classification. To verify its accuracy, the proposed method was used to analyze 90 CT scans with 652 nodules. The experimental results revealed that the proposed method had an accuracy of 97.87% and produced 1.52 false positives per scan (FPs/scan), indicating that the proposed method has high accuracy and low FPR.

ACRIPPER: A New Associative Classification Based on RIPPER Algorithm

Associative Classification (AC) classifiers are of substantial interest due to their ability to be utilised for mining vast sets of rules. However, researchers over the decades have shown that a large number of these mined rules are trivial, irrelevant, redundant, and sometimes harmful, as they can cause decision-making bias. Accordingly, in our paper, we address these challenges and propose a new novel AC approach based on the RIPPER algorithm, which we refer to as ACRIPPER. Our new approach combines the strength of the RIPPER algorithm with the classical AC method, in order to achieve: (1) a reduction in the number of rules being mined, especially those rules that are largely insignificant; (2) a high level of integration among the confidence and support of the rules on one hand and the class imbalance level in the prediction phase on the other hand. Our experimental results, using 20 different well-known datasets, reveal that the proposed ACRIPPER significantly outperforms the well-known rule-based algorithms RIPPER and J48. Moreover, ACRIPPER significantly outperforms the current AC-based algorithms CBA, CMAR, ECBA, FACA, and ACPRISM. Finally, ACRIPPER is found to achieve the best average and ranking on the accuracy measure.